Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia

Similar documents
FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Antipsychotic Medications

Rexulti (brexpiprazole)

Screening tools for elderly patients in primary care

Outpatient use of Atypical Antipsychotic Agents in the Pediatric Population Years

MEDICATIONS PRESCRIPTION AT HOSPITAL DISCHARGE IN PATIENTS WITH VALIDATED DIAGNOSIS OF DEMENTIA. Federica Edith Pisa University Hospital Udine

DEMENTIA AND MEDICATION

Platforms for Performance: Clinical Dashboards to Improve Quality and Safety 2011 Midyear Clinical Meeting

Advancements in the Assessment of Medication Adherence: A Panel Discussion and Case Study. Finding Clarity in the Midst of Uncertainty

DIABETES ASSOCIATED WITH ANTIPSYCHOTIC USE IN VETERANS WITH SCHIZOPHRENIA

Changing patterns of sedative use over time in older adults in Ontario

Katee Kindler, PharmD, BCACP

Table of Contents. 1.0 Policy Statement...1

VCU Scholars Compass. Virginia Commonwealth University. Della Varghese Virginia Commonwealth University

Application of EventFlow to Model the Complexity and Continuity of Antipsychotic Use Among Youth

Policy Evaluation: Low Dose Quetiapine Safety Edit

Drug Use Evaluation: Low Dose Quetiapine

Appendix D: Included Studies adverse effects review

The Role of Pharmacists achieving international best practice standards and realising key opportunities.

Integrating INTERACT into Interim Pharmacist Reviews

The Louis de la Parte Florida Mental Health Institute

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety

Title: Antipsychotic Use in Persons with Dementia CMS ID: ARCO3 NQF #: N/A

Psychosis and Agitation in Dementia

A Retrospective Claims Analysis of Medication Adherence and. Persistence Among Patients Taking Antidepressants

Silvia Duong, 1,2 Kam-Tong Yeung, 1 and Feng Chang 1,3. 1. Introduction

Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives

Prescribing for people with a personality disorder. POMH-UK QIP 12b

Psychotropic Drug Therapy in Adults with Learning Disability. Steve Wilkinson

Canadian Practices for the Treatment of Delirium. Lisa Burry, BScPharm, PharmD

Hearts and Minds An ECG Update. Tuesday 18 th November The Met Hotel, Leeds

PRESCRIPTION PATTERNS OF PSYCHOTROPIC DRUGS

Introducing ValueOptions Clinical Care Alerts

Drugs used in schizophrenia قادة فریق علم الا دویة : الشكر موصول لا عضاء الفریق المتمیزین :

COMBATTING THE EXCESSIVE AND ILLEGAL USE OF PSYCHOTROPIC DRUGS ON PEOPLE WITH DEMENTIA IN NURSING FACILITIES

MORTALITY ASSOCIATED WITH USE OF ANTIPSYCHOTICS IN DEMENTIA: REVIEWING THE EVIDENCE

Pharmacology in the Elderly

Supplementary Online Content

Schizophrenia, a devastating chronic. Treatment Adherence Associated With Conventional and Atypical Antipsychotics in a Large State Medicaid Program

MENTAL HEALTH SERVICES 2010 MEDICATION

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit

A Basic Approach to Mood and Anxiety Disorders in the Elderly

METHODS RESULTS. Supported by funding from Ortho-McNeil Janssen Scientific Affairs, LLC

9: 3 TABLE OF CONTENTS P&T

The place for treatments of associated neuropsychiatric and other symptoms

Atypical Antipsychotic Use for the Behavioural and Psychological Symptoms of Dementia in the Elderly

Psychotropic Medication Use in Canadian Long-Term Care Patients Referred for Psychogeriatric Consultation

Psychotropic Strategies Handout Package

Rational prescribing in the older adult. Assoc Prof Craig Whitehead

Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia Number Needed to Harm

CHLORPROMAZINE EQUIVALENTS VERSUS DEFINED DAILY DOSES: HOW TO COMPARE ANTIPSYCHOTIC DRUG DOSES?

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition

PHARMACOLOGICAL THERAPY OF AUTISM SPECTRUM DISORDERS IN THE CLINICAL PRACTICE

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA

Psychotropic Medications: What s New?

Safety Profile Assessment of Risperidone and Olanzapine in Long-Term Care Patients with Dementia

Pharmacological Treatment of Aggression in the Elderly

Use of Mood Stabilizers to launch the use of combination treatments with mood stabilizers and antipsichotics for a variety of conditions, such as cont

OBJECTIVES. Achieving Success in Reducing Inappropriate Use of Antipsychotic Medication in Patients with Dementia

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety

Prevalence of Comorbidity and Pattern Drug Use among Children with Attention-deficit hyperactivity disorder: A Single Center in Thailand

Drug utilization pattern of patients with bipolar affective disorder in a tertiary care hospital in India

Research Protocol for REAP Bipolar Disorder (REAP-BD)

Evaluation of a Medicaid Psychotropic Drug Management Program in Utah

Research. Sebastian Schneeweiss, Soko Setoguchi, Alan Brookhart, Colin Dormuth, Philip S. Wang. Methods

Mental Health Subcommittee of PTAC meeting held 21 June (minutes for web publishing)

Lithium in bipolar disorders.

PDFlib PLOP: PDF Linearization, Optimization, Protection. Page inserted by evaluation version

Atypical antipsychotics are associated with undesirable

Effective Health Care Program

David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Antipsychotic Medications Age and Step Therapy

Pharmacologyonline 1: (2009) ewsletter Rosanna Erra. Atypical Antipsychotic Drugs for the Treatment of BPSD. in Subjects with Dementia

University of Groningen. Pharmacy data as a tool for assessing antipsychotic drug use Rijcken, Claudia

Psychotropic Medication. Including Role of Gradual Dose Reductions

Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009

The Maudsley Prescribing Guidelines in

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

PRESCRIBING GUIDELINES

Supplementary Methods

RESEARCH. What is already known about this subject

Antipsychotics Detect, Select, Effect (P.I.E.C.E.S. 6 th Ed)

Effects of Home Antipsychotic Reinitiation in ICU Patients with a History of Mental Illness

MEDICATIONS IN MANAGING DIFFICULT BEHAVIORS

PRESCRIPTION PATTERNS AT DISCHARGE FROM HOSPITALISATION IN OLDER ADULTS WITH SEVERE MENTAL ILLNESS

Proposed Changes to Existing Measure for HEDIS : Adherence to Antipsychotic Medications for Individuals With Schizophrenia (SAA)

METROHEALTH PSYCHIATRY RESIDENCY EVIDENCE-BASED MENTAL HEALTH JOURNAL

University of Groningen. Metabolic risk in people with psychotic disorders Bruins, Jojanneke

Evaluation of Florida Medicaid Behavioral Pharmacy Practice by Racial/Ethnic Minorities Across the Lifespan

The burden of psychotropic drug prescribing in people with dementia: a population database study

Nuplazid. Nuplazid (pimavanserin) Description

Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer s disease in Finland

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD

NeuroPharmac Journal ISSN: Alzheimer s Disease: Pharmacotherapy of noncognitive symptoms Aslam Pathan; Abdulrahman M.

Antipsychotic Use in the Elderly

Polypharmacy and Deprescribing for Older People

Prevalence of Polypharmacy in Geriatric Patients in Rural Teaching Hospital

Risks of Antipsychotics use In Dementia

Transcription:

Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia Aine Leen, Kieran Walsh, David O Sullivan, Denis O Mahony, Stephen Byrne, Margaret Bermingham Pharmaceutical Care Research Group, School of Pharmacy, University College Cork.

Background Antipsychotics are used in the treatment of behavioral and psychological symptoms of dementia despite limited evidence. Long-standing evidence of increased risk of cerebrovascular events and mortality among people with dementia prescribed antipsychotic therapy (Schneider et al, JAMA 2005). Recent Irish data (Walsh et al, 2016), 14% hospitalised patients with dementia prescribed an antipsychotic Patients with dementia 4x more likely to be prescribed antipsychotic than those w/o dementia.

Aims 1. To estimate the prevalence of antipsychotic prescription among elderly residents in Irish long term care facilities. 2. To establish the clinical factors associated with antipsychotic prescription among the total population and among patients with dementia in this setting.

Methods Retrospective, observational, cohort study. Residents in 14 long term care facilities in Cork region. Data collection: From residents medical files Performed by single individual in 2009/10. Includes demographics, medications, diagnoses. Inclusion criteria: All residents 65 years. Exclusion criteria: Diagnosis of schizophrenia, bipolar affective disorder.

Methods Dementia was identified by record of: Dementia Alzheimer s disease Cognitive impairment Antipsychotic prescription defined as: Regular prescription Excluded prescription of prochlorperazine Comparisons by t-test (continuous data) and χ 2 test (categorical). Cox regression analysis To estimate multivariable associates of antipsychotic prescription.

Total Population Characteristic Total population N = 695 Age (years) 83.9 ± 7.8 Male 218 (29.8%) Co-morbidities Number of medical conditions 10.5 ± 4.0 Dementia 360 (51.8%) Medications Number of medications prescribed 11.3 ± 3.7 Dementia Pharmacotherapy 57 (8.2%) Antipsychotic agent (regular) 177 (25.5%) Antipsychotic agent (as required) 48 (6.9%) Antidepressant 302 (43.5%) Benzodiazepine (regular) 202 (29.1%)

Total population Characteristic Residents with Dementia, n = 360 Residents without dementia, n = 335 Age (years) * 84.9 ± 7.1 83.6 ± 8.2 Male 96 (26.7%) 111 (33.1%) Antipsychotic, regular * 112 (31.1%) 65 (19.4%) Antipsychotic, as required 29 (8.1%) 19 (5.7%) Antidepressant * 141 (39.2%) 161 (48.1%) Benzodiazepine, regular 106 (29.4%) 96 (28.7) Number of medicines prescribed * 11.8 ± 3.9 10.8 ± 3.5 Number of medical conditions 10.2 ± 4.0 10.9 ± 4.0 * Indicates p-value <0.05 for comparison between residents with dementia and those without dementia.

Residents with dementia Characteristic Dementia and Antipsychotic, n= 112 Dementia and No Antipsychotic, n= 248 Age (years) * 83.5 ± 7.2 85.5 ± 7.0 Male 37 (33.0%) 59 (23.8%) Antipsychotic, as required * 20 (18.1%) 9 (3.6%) Antidepressant 51 (45.5%) 90 (36.3%) Benzodiazepine, regular * 44 (39.6%) 62 (24.9%) Number of medicines prescribed * 11.6 ± 3.2 10.4 ± 3.6 Number of medical conditions 11.1 ± 4.2 10.7 ± 3.9 * Indicates p-value <0.05 for comparison between residents with dementia and those without dementia.

Antipsychotic agents prescribed Regular antipsychotic prescribed to 177 residents Second antipsychotic prescribed to 7 residents Atypical antipsychotics prescribed more among residents with dementia (86.2%) and residents without dementia (95.6%). Quetiapine accounted for 57.6% of all antipsychotics prescribed Followed by: Olanzapine (16.8%) Risperidone (9.8%) Haloperidol (8.7%)

Associates of antipsychotic use Characteristic Multivariable associates of prescription of antipsychotic in total population (Odds ratio, 95% Confidence Interval) Age 0.98 (0.96 1.00) Male sex 1.11 (0.73 1.63) Dementia 1.94 (1.35 2.79) Antidepressant 1.26 (0.87 1.82) Benzodiazepine, regular 1.92 (1.31 2.81) Number of medicines prescribed 1.05 (0.99 1.11) Among residents with dementia associates of antipsychotic use were: 1. Regular benzodiazepine (OR = 1.70, 95% CI 1.02 2.81) and 2. Number of medicines prescribed (OR = 1.08, 95% CI 1.01 1.15)

Study limitations Retrospective Single time-point data Absence of outcome data

Conclusion This retrospective study shows that elderly residents in long term care have a high rate of antipsychotic prescription. Residents with Dementia and prescribed antipsychotic are younger, have greater polypharmacy and greater use of other psychotropic agents. Results highlight long term care residents at greatest risk of antipsychotic use.